Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Batia Avni"'
Autor:
Arielle Jacover, Yonaton Zarbiv, Keidar Haran Tal, Shira Klein, Shani Breuer, Ronen Durst, Batia Avni, Sigal Grisariu, Polina Stepensky, Michal Lotem, Ofra Maimon, Tamar Yablonski‐Peretz
Publikováno v:
Cancer Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)
Abstract Background Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that is treated with chemotherapy. Recently, programmed death 1 (PD1) inhibition, as well as antibody‐drug conjugates, have been added to the available
Externí odkaz:
https://doaj.org/article/35069d56b7044ff99868e160fb5d34f0
Autor:
Ido Brami, Tsila Zuckerman, Ron Ram, Batia Avni, Galit Peretz, Daniel Ostrovsky, Yotam Lior, Caroline Faour, Oisin McElvaney, Noel G. McElvaney, Eli C. Lewis
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 422 (2023)
α1-Antitrypsin (AAT), an acute-phase reactant not unsimilar to C-reactive protein (CRP), is a serine protease inhibitor that harbors tissue-protective and immunomodulatory attributes. Its concentrations appropriately increase during conditions of ex
Externí odkaz:
https://doaj.org/article/06a97daf5c92472e935ac2178e4a0801
Autor:
Andrea Fracchia, Drirh Khare, Samar Da’na, Reuven Or, Amnon Buxboim, Boaz Nachmias, Claudine Barkatz, Regina Golan-Gerstl, Swasti Tiwari, Polina Stepensky, Yuval Nevo, Hadar Benyamini, Sharona Elgavish, Osnat Almogi-Hazan, Batia Avni
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 18, p 13689 (2023)
Recent studies have highlighted the therapeutic potential of small extracellular bodies derived from mesenchymal stem cells (MSC-sEVs) for various diseases, notably through their ability to alter T-cell differentiation and function. The current study
Externí odkaz:
https://doaj.org/article/71bdc765d92a40aa9656037325544fdc
Autor:
Nathalie Asherie, Shlomit Kfir-Erenfeld, Batia Avni, Miri Assayag, Tatyana Dubnikov, Nomi Zalcman, Eyal Lebel, Eran Zimran, Adir Shaulov, Marjorie Pick, Yael Cohen, Irit Avivi, Cyrille Cohen, Moshe E. Gatt, Sigal Grisariu, Polina Stepensky
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
Anti-B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR T) therapy shows remarkable efficacy in patients with relapsed and/or refractory (R/R) multiple myeloma (MM). HBI0101, a novel second generation optimized anti- BCMA CAR T-ce
Externí odkaz:
https://doaj.org/article/40a8d177594b49e183117e6a58b4f391
Autor:
Vladimir Vainstein, Batia Avni, Sigal Grisariu, Shlomit Kfir-Erenfeld, Nathalie Asherie, Boaz Nachmias, Shlomtzion Auman, Revital Saban, Eran Zimran, Miri Assayag, Kalman Filanovsky, Netanel A. Horowitz, Eyal Lebel, Adir Shaulov, Michal Gur, Chaggai Rosenbluh, Svetlana Krichevsky, Polina Stepensky, Moshe E. Gatt
Publikováno v:
Cancers, Vol 15, Iss 13, p 3471 (2023)
Multiple myeloma (MM) is characterized by recurrent relapses. Consequently, patients receive multiple therapy lines, including alkylating agents and immune modulators, which have been associated with secondary malignancies such as myelodysplastic syn
Externí odkaz:
https://doaj.org/article/4e10ec35b94641e099d8b3dcc636a5de
Autor:
Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay, Ilana Slouzkey, Tsila Zuckerman
Publikováno v:
Vaccines, Vol 11, Iss 4, p 775 (2023)
COVID-19-related mortality among hematopoietic stem cell transplantation (HSCT) recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech BNT162b2 vaccine demonstrated significant immunogenicity and efficacy in the healthy popu
Externí odkaz:
https://doaj.org/article/94348d0ee029449fa530060c7aaf3ce8
Autor:
Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sarid, Yair Herishanu, Ronit Gold, Chen Glait-Santar, Sigi Kay, Irit Avivi
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Data regarding efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in the elderly, geriatric population are insufficient. In 2019, tisagenlecleucel and axicabtagene-ciloleucel were commercially approved for relapsed/refractory d
Externí odkaz:
https://doaj.org/article/ee6304dbe547454693562f57a4f69b46
Autor:
Rajni Sharma, Manju Kumari, Suman Mishra, Dharmendra K. Chaudhary, Alok Kumar, Batia Avni, Swasti Tiwari
Publikováno v:
Journal of Diabetes Research, Vol 2021 (2021)
Mesenchymal stem cell (MSC) therapy is an innovative approach in diabetes due to its capacity to modulate tissue microenvironment and regeneration of glucose-responsive insulin-producing cells. In this study, we investigated the role of MSC-derived e
Externí odkaz:
https://doaj.org/article/49ac76876f5049568f2202e7c56e5b30
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Background: Bone marrow mesenchymal stem cells (bmMSC) may play a role in the regulation of maturation, proliferation, and functional activation of lymphocytes, though the exact mechanisms are unknown. MSC-derived exosomes induce a regulatory respons
Externí odkaz:
https://doaj.org/article/32a022e501a046969f5616b296589c8f
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187722 (2017)
Early detection of relapsed lymphoma improves response and survival. Current tools lack power for detection of early relapse, while being cumbersome and expensive. We searched for sensitive biomarkers that precede clinical relapse, and serve for furt
Externí odkaz:
https://doaj.org/article/ffc9def37dc640c992996a5872a2ad51